biomedical | Science and Enterprise

New post on Science and Enterprise: Taking a Break https://t.co/QgH851GMZX #Science #Business
about 2 days ago
Total venture capital funding in the U.S. for first six months of 2019 reached levels not seen since the year 2000,… https://t.co/cGSC6j1Xl8
about 2 days ago
New post on Science and Enterprise: Infographic – U.S. Venture Funds Near 20-Year Highs https://t.co/mIkraoGRAH #Science #Business
about 2 days ago
A set of computational tools developed at Purdue University enables public safety agencies to monitor potentially c… https://t.co/NHSLm9YBBG
about 3 days ago
New post on Science and Enterprise: A.I. Helps Visualize Emergency Social Media Data https://t.co/E94lXHnPsa #Science #Business
about 3 days ago

Hearing Loss Cell Therapy Licensed in $625M Deal

By Alan, on July 18th, 2019%

A biotechnology company developing regenerative treatments for various disorders is licensing its lead therapy candidate for hearing loss to Astellas Pharma. . . . → Read More: Hearing Loss Cell Therapy Licensed in $625M Deal

Smart Fabrics Boost Wearable Sensor Connections

By Alan, on July 17th, 2019%

A new type of smart fabric can dramatically improve connectivity between wearable sensors and mobile devices compared to current wireless networks. . . . → Read More: Smart Fabrics Boost Wearable Sensor Connections

Genentech, Biotech Partner on Multiple Sclerosis

By Alan, on July 16th, 2019%

A company designing treatments to restore the protective coating on nerve cells damaged by multiple sclerosis is collaborating with biotechnology enterprise Genentech. . . . → Read More: Genentech, Biotech Partner on Multiple Sclerosis

Trial to Test App Alerting for Dementia-Linked Drugs

By Alan, on July 15th, 2019%

A mobile and computer app that alerts older citizens about a class of drugs associated with Alzheimer’s disease will soon be tested in a clinical trial. . . . → Read More: Trial to Test App Alerting for Dementia-Linked Drugs

Trial Shows Immunotherapies Extend Life with Melanoma

By Alan, on July 15th, 2019%

First results from a clinical trial show a combination of immunotherapies extends survival among patients with melanoma, but shorter periods for other solid-tumor cancers. . . . → Read More: Trial Shows Immunotherapies Extend Life with Melanoma

Anti-Smoking Ads Not Reaching Most in U.S.

By Alan, on July 12th, 2019%

A nationwide survey shows a majority of American adults, including half of those who smoke, did not see court-ordered anti-smoking TV or newspaper advertisements. . . . → Read More: Anti-Smoking Ads Not Reaching Most in U.S.

Crispr Enhanced for RNA Editing

By Alan, on July 12th, 2019%

Researchers expanded the ability of the genetic editing technique known as Crispr to alter the make-up of RNA, adding more ways to treat diseases. . . . → Read More: Crispr Enhanced for RNA Editing

Bacteria Recruited to Produce Graphene

By Alan, on July 11th, 2019%

Labs in the U.S. and the Netherlands developed techniques to sustainably produce high-quality graphene with more capabilities, using a strain of bacteria. . . . → Read More: Bacteria Recruited to Produce Graphene

Analysis – Most New Drugs Not Adding Patient Benefits

By Alan, on July 11th, 2019%

An analysis of drugs approved for use in Germany since 2011 shows no evidence most treatments provide new or added benefits to patients compared to standard care. . . . → Read More: Analysis – Most New Drugs Not Adding Patient Benefits

Cold-Chain Drug Delivery Tested Via Drone

By Alan, on July 10th, 2019%

A group of companies and organizations designed and tested a long-distance drone capable of delivering drugs needing constant cold temperatures. . . . → Read More: Cold-Chain Drug Delivery Tested Via Drone

Science & Enterprise subscription

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise